Ergoteles LLC Quotient LTD Transaction History

Ergoteles LLC

$68.2 Billion
Q3 2023

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$0.16 - $0.31 $21,657 - $41,960	-135,357 Reduced 34.59%	255,943 $38,000
Q2 2022 Aug 12, 2022	BUY	$0.24 - $1.2 $93,912 - $469,560	391,300 New	391,300 $94,000
Q4 2021 Feb 14, 2022	SELL	$1.89 - $3.12 $77,490 - $127,920	-41,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.34 - $3.77 $33,462 - $53,911	14,300 Added 53.56%	41,000 $96,000
Q2 2021 Aug 12, 2021	BUY	$3.48 - $4.45 $92,916 - $118,815	26,700 New	26,700 $97,000
Q4 2020 Feb 11, 2021	SELL	$4.4 - $7.32 $45,760 - $76,128	-10,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.38 - $8.35 $45,552 - $86,840	10,400 New	10,400 $53,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.